Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method

Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method

Exosomes, nanosized membrane vesicles secreted by cardiac progenitor cells (Exo-CPC), inhibit cardiomyocyte apoptosis under stress conditions, promote angiogenesis in vitro, and prevent the early decline in cardiac function after myocardial infarction in vivo in preclinical rat models. The recogniti...

Full description

Bibliographic Details
Main Authors: Gabriella Andriolo, Elena Provasi, Viviana Lo Cicero, Andrea Brambilla, Sabrina Soncin, Tiziano Torre, Giuseppina Milano, Vanessa Biemmi, Giuseppe Vassalli, Lucia Turchetto, Lucio Barile, Marina Radrizzani
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Physiology
Subjects:
exosomes
cardiac progenitor cells
good manufacturing practices
large-scale production
quality control
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.01169/full

Internet

https://www.frontiersin.org/article/10.3389/fphys.2018.01169/full

Similar Items